Chimerix Announces Positive Topline Results for ONC201 in Recurr

CMRX: Chimerix, Inc.
2021-11-04 07:00:00
Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma
Beyond Technical Analysis

Exención de responsabilidad